COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1618: Articles 16171-16180  | Next

Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19
Dean, M. J., Ochoa, J. B., Sanchez-Pino, M., Zabaleta, J., Garai, J., del Valle, L., Wyczechowska, D., Buckner Baiamonte, L., Philbrook, P., Majumder, R., Vander Heide, R., Dunkenberger, L., Thylur, R., Nossaman, R., Roberts, W. M., Chapple, A., Collins, J., Luke, B., Johnson, R., Koul, H., Rees, C. A., Morris, C. R., Garcia-Diaz, J., Ochoa, A. C.
10.1101/2021.03.26.21254441 — Posted: 2021-03-29
De novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic Response
Kothakonda, A., Atta, L., Plana, D., Ward, F., Davis, C., Cramer, A., Moran, R., Freake, J., Tian, E., Mazor, O., Gorelik, P., Van, C., Hansen, C., Yang, H., Sinha, M. S., Li, J., Yu, S. H., LeBoeuf, N. R., Sorger, P. K.
10.1101/2021.03.25.21252076 — Posted: 2021-03-29
A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention
Witus, L. S., Larson, E.
10.1101/2021.03.26.21254433 — Posted: 2021-03-29
Logistic Formula in Biology and Its Application to COVID-19 in Japan
Saito, T., Kokado, A.
10.1101/2021.03.24.21254279 — Posted: 2021-03-29
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines
Kennedy, N. A., Lin, S., Goodhand, J. R., Chanchlani, N., CLARITY IBD Contributors, , Powell, N., Ahmad, T.
10.1101/2021.03.25.21254335 — Posted: 2021-03-28 Discussion: Onsite
A unique SARS-CoV-2 spike protein P681H strain detected in Israel
Zuckerman, N. S., Fleishon, S., Bucris, E., Bar-Ilan, D., Linial, M., Bar-Or, I., Indenbaum, V., Weil, M., Israel National Consortium for SARS-CoV-2 sequencing, , Mendelson, E., Mandelboim, M., Mor, O.
10.1101/2021.03.25.21253908 — Posted: 2021-03-28
Early experiences of rehabilitation for patients post-COVID to improve fatigue, breathlessness exercise capacity and cognition.
Daynes, E., Gerlis, C., Chaplin, E., Gardiner, N., Singh, S. J.
10.1101/2021.03.25.21254293 — Posted: 2021-03-28
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
Jablonska, K., Aballea, S., Auquier, P., Toumi, M.
10.1101/2021.03.25.21254289 — Posted: 2021-03-28
The new SARS-CoV-2 variant and reinfection in the resurgence of COVID-19 outbreaks in Manaus, Brazil
He, D., Fan, G., Wang, X., Li, Y., Peng, Z.
10.1101/2021.03.25.21254281 — Posted: 2021-03-28
Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy
Di Giallonardo, F., Puglia, I., Curini, V., Camma, C., Mangone, I., Calistri, P., Cobbin, J. C., Holmes, E. C., Lorusso, A.
10.1101/2021.03.24.21254277 — Posted: 2021-03-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).